Published in Ann Surg on July 01, 2003
Cholangiocarcinoma--controversies and challenges. Nat Rev Gastroenterol Hepatol (2011) 2.11
Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma. J Gastrointest Surg (2015) 2.03
Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg (2006) 2.03
Surgical management of hilar cholangiocarcinoma. Ann Surg (2005) 1.80
One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg (2006) 1.64
Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg (2008) 1.60
Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg (2007) 1.58
Current surgical treatment for bile duct cancer. World J Gastroenterol (2007) 1.30
Clinical significance of reconstruction of the right hepatic artery for biliary malignancy. Langenbecks Arch Surg (2006) 1.24
Role of surgery in colorectal cancer liver metastases. World J Gastroenterol (2014) 1.13
Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford) (2009) 1.06
Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB (Oxford) (2008) 1.05
Preoperative cholangitis independently increases in-hospital mortality after combined major hepatic and bile duct resection for hilar cholangiocarcinoma. Langenbecks Arch Surg (2009) 1.03
Preoperative biliary drainage increases infectious complications after hepatectomy for proximal bile duct tumor obstruction. World J Surg (2009) 1.01
Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg (2008) 1.00
Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality. World J Surg (2014) 0.98
Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma. HPB (Oxford) (2009) 0.98
Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Rev Gastroenterol Hepatol (2012) 0.97
Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg (2014) 0.97
Impact of tumor spread to the cystic duct on the prognosis of patients with gallbladder carcinoma. World J Surg (2007) 0.96
Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review. Dig Dis Sci (2010) 0.93
Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol (2011) 0.92
Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics. J Gastroenterol (2012) 0.92
Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection? Ann Surg Oncol (2009) 0.91
Perihilar cholangiocarcinoma: Current therapy. World J Gastrointest Pathophysiol (2014) 0.90
Definition of microscopic tumor clearance (r0) in pancreatic cancer resections. Cancers (Basel) (2010) 0.90
Principles of surgical resection in hilar cholangiocarcinoma. World J Gastrointest Oncol (2013) 0.90
Pathological aspects of so called "hilar cholangiocarcinoma". World J Gastrointest Oncol (2013) 0.90
Cholangiocellular carcinoma--the role of caudate lobe resection and mesohepatectomy. HPB (Oxford) (2008) 0.89
Surgical resection for hilar cholangiocarcinoma: experience improves resectability. HPB (Oxford) (2011) 0.89
Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) (2008) 0.88
Differentiation of malignant and benign proximal bile duct strictures: the diagnostic dilemma. World J Gastroenterol (2008) 0.88
Preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma. HPB (Oxford) (2005) 0.88
Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis (2014) 0.88
Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol (2013) 0.88
Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma. World J Gastroenterol (2012) 0.86
Hilar cholangiocarcinoma: tumor depth as a predictor of outcome. Arch Surg (2011) 0.85
Major but not minor hepatectomy accelerates engraftment of extrahepatic tumor cells. Clin Exp Metastasis (2007) 0.85
Endoscopic inside stent placement is suitable as a bridging treatment for preoperative biliary tract cancer. BMC Gastroenterol (2015) 0.84
Safety and effectiveness of left hepatic trisegmentectomy for hilar cholangiocarcinoma. World J Surg (2005) 0.84
Operable malignant jaundice: To stent or not to stent before the operation? World J Gastrointest Endosc (2010) 0.84
Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant. J Am Coll Surg (2016) 0.84
Survival benefit of hepatopancreatoduodenectomy for cholangiocarcinoma in comparison to hepatectomy or pancreatoduodenectomy. World J Surg (2010) 0.84
Therapeutical concepts and results for Klatskin tumors. Dtsch Arztebl Int (2008) 0.83
Changing perspectives in the assessment of resectability of hilar cholangiocarcinoma. Ann Surg Oncol (2007) 0.83
Liver transplantation for hilar cholangiocarcinoma. World J Gastroenterol (2013) 0.83
Liver resection for Bismuth type I and Type II hilar cholangiocarcinoma. World J Surg (2013) 0.81
Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma. Sci Rep (2015) 0.81
Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy. World J Gastroenterol (2013) 0.80
Surgical resection techniques for locally advanced hilar cholangiocarcinoma. Langenbecks Arch Surg (2014) 0.79
Flowcharts for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg (2008) 0.79
Patient preparation before surgery for cholangiocarcinoma. HPB (Oxford) (2008) 0.79
Strategies for resection using portal vein embolization: hepatocellular carcinoma and hilar cholangiocarcinoma. Semin Intervent Radiol (2008) 0.79
Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China. World J Gastroenterol (2016) 0.79
Post-hepatectomy liver failure in patients with colorectal liver metastases. Surg Today (2015) 0.78
Impact of lymph node micrometastasis in hilar bile duct carcinoma patients. World J Gastroenterol (2006) 0.78
Tumour size over 3 cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 group. HPB (Oxford) (2014) 0.78
Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer. World J Surg Oncol (2012) 0.78
Guidelines for palliative surgery of cholangiocarcinoma. HPB (Oxford) (2008) 0.78
The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade? World J Surg (2015) 0.78
Duct-to-duct biliary reconstruction after radical resection of Bismuth IIIa hilar cholangiocarcinoma. World J Gastroenterol (2013) 0.77
Local surgical resection of hilar cholangiocarcinoma: is there still a place? HPB (Oxford) (2008) 0.76
Surgical and Radiological Studies on the Length of the Hepatic Ducts. World J Surg (2015) 0.76
Improved surgical outcomes for hilar cholangiocarcinoma: changes in surgical procedures and related outcomes based on 40 years of experience at a single institution. Surg Today (2015) 0.76
Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases. Ann Surg Oncol (2015) 0.75
Rapidly aggravated skeletal muscle metastases from an intrahepatic cholangiocarcinoma. World J Gastroenterol (2015) 0.75
High dose chemoradiation for unresectable hilar cholangiocarcinomas using intensity modulated external beam radiotherapy: a single tertiary care centre experience. J Gastrointest Oncol (2017) 0.75
Transhepatic Hilar Approach for Perihilar Cholangiocarcinoma: Significance of Early Judgment of Resectability and Safe Vascular Reconstruction. J Gastrointest Surg (2016) 0.75
Safety validation of decision trees for hepatocellular carcinoma. World J Gastroenterol (2015) 0.75
Combined portal vein resection for hilar cholangiocarcinoma. Int J Clin Exp Med (2015) 0.75
Detection of Primary Malignancy and Metastases with FDG PET/CT in Patients with Cholangiocarcinomas: Lesion-based Comparison with Contrast Enhanced CT. World J Nucl Med (2016) 0.75
Risk factors for a high Comprehensive Complication Index score after major hepatectomy for biliary cancer: a study of 229 patients at a single institution. HPB (Oxford) (2016) 0.75
Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme. J Am Coll Surg (2016) 0.75
Intranuclear accumulation of galectin-3 is an independent prognostic factor for patients with distal cholangiocarcinoma. Oncol Lett (2017) 0.75
Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis. Surg Today (2016) 0.75
Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma? Oncotarget (2017) 0.75
Isolated caudate lobectomy with pancreatoduodenectomy for a bile duct cancer. Langenbecks Arch Surg (2013) 0.75
The type of preoperative biliary drainage predicts short-term outcome after major hepatectomy. Langenbecks Arch Surg (2016) 0.75
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
V. Notes on the Arrest of Hepatic Hemorrhage Due to Trauma. Ann Surg (1908) 4.70
ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES. Am J Med (1965) 4.22
Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet (1975) 4.17
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery (1990) 3.93
Management strategies in resection for hilar cholangiocarcinoma. Ann Surg (1992) 3.69
Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet (1982) 3.52
Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology (1997) 3.28
Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg (1985) 3.19
Extended resections for hilar cholangiocarcinoma. Ann Surg (1999) 2.93
Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg (1996) 2.54
Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg (1981) 2.53
No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg (1999) 2.47
Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts. Lancet (1984) 2.28
Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg (1999) 2.24
Research into the results of resection of hilar bile duct cancer. Surgery (1990) 2.18
Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol (1997) 2.16
Prediction of risk in biliary surgery. Br J Surg (1983) 2.07
Carcinoma of the hepatic hilus. Surgical management and the case for resection. Ann Surg (1979) 2.05
Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg (2001) 1.99
The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg (1998) 1.90
Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg (1999) 1.83
Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery (1994) 1.73
Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg (1992) 1.69
Preoperative portal vein embolization: an audit of 84 patients. Hepatology (1999) 1.64
Major liver resection for hilar cholangiocarcinoma. Ann Surg (1988) 1.60
Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg (1989) 1.59
Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma--a single center experience. Surgery (2000) 1.55
Proximal bile duct cancer. Quality of survival. Ann Surg (1987) 1.54
Tumor seeding from percutaneous biliary catheters. Ann Surg (1989) 1.41
Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg (1999) 1.37
Major liver resection for carcinoma in jaundiced patients without preoperative biliary drainage. Arch Surg (2000) 1.37
Efficacy of preoperative biliary tract decompression in patients with obstructive jaundice. Arch Surg (1984) 1.31
Preoperative intrahepatic segmental cholangitis in patients with advanced carcinoma involving the hepatic hilus. Surgery (1996) 1.30
Outcome of extended right hepatectomy after biliary drainage in hilar bile duct cancer. Arch Surg (1995) 1.24
Technique of inserting multiple biliary drains and management. Hepatogastroenterology (1996) 1.19
Right portal vein embolization in preparation for major hepatic resection. J Am Coll Surg (1995) 1.17
Segmental liver resections for hilar cholangiocarcinoma. Hepatogastroenterology (1998) 1.13
Outcome of major hepatectomy with pancreatoduodenectomy for advanced biliary malignancies. World J Surg (1996) 1.10
Radical operation after portal embolization for tumor of hilar bile duct. J Am Coll Surg (1994) 1.10
A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery (1999) 1.07
Second-stage pancreatojejunostomy following pancreatoduodenectomy in high-risk patients. Am J Surg (1994) 1.05
Appraisal of two-staged pancreatoduodenectomy: its technical aspects and outcome. Hepatogastroenterology (2000) 1.00
Resectability and functional reserve of the liver with obstructive jaundice in dogs. Am J Surg (1979) 0.93
The role of preoperative biliary decompression in obstructive jaundice. Hepatogastroenterology (1996) 0.90
Selective versus total drainage for biliary obstruction in the hepatic hilus: an experimental study. Surgery (2001) 0.89
Reconstruction of small and fragile bile ducts without mucosa-to-mucosa anastomosis. Arch Surg (2000) 0.88
Recovery patterns of liver function after complete and partial surgical biliary decompression. Am J Surg (1996) 0.86
Recovery of liver functions following surgical biliary decompression in obstructive jaundice. Hepatogastroenterology (1998) 0.85
Two-staged pancreatoduodenectomy with external drainage of pancreatic juice and omental graft technique. J Am Coll Surg (1998) 0.83
Portal embolization relieves persistent jaundice after complete biliary drainage. Surgery (2001) 0.82
The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg (2009) 16.82
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol (2003) 6.14
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet (2012) 4.84
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology (2008) 4.61
Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery (2011) 4.40
Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med (2002) 4.25
Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg (2005) 4.13
High-resolution characterization of a hepatocellular carcinoma genome. Nat Genet (2011) 3.86
One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg (2003) 3.84
Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis (2011) 3.74
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology (2006) 3.68
Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res (2006) 3.38
Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg (2007) 3.33
Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery (2011) 3.16
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma. Eur J Cancer (2011) 2.81
Marginal survival benefit in the treatment of early hepatocellular carcinoma. J Hepatol (2012) 2.77
Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol (2008) 2.64
Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg (2008) 2.43
Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma. Cancer Res (2004) 2.34
Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res (2007) 2.29
FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res (2007) 2.21
Operative morbidity of living liver donors in Japan. Lancet (2003) 2.13
G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells. Biochem Biophys Res Commun (2002) 2.13
Regeneration and function of hemiliver graft: right versus left. Surgery (2006) 2.12
Prophylactic impact of endoscopic treatment for esophageal varices in liver resection: a prospective study. J Gastroenterol (2013) 2.08
Impact of surgery on quality of life in patients with hepatocellular carcinoma. World J Surg (2014) 2.06
Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery (2008) 2.04
Bloodless liver resection using the monopolar floating ball plus ligasure diathermy: preliminary results of 16 liver resections. World J Surg (2004) 2.04
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer (2004) 2.03
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg (2003) 2.01
Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res (2008) 1.91
Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol (2006) 1.89
The vessel sealing system (LigaSure) in hepatic resection: a randomized controlled trial. Ann Surg (2009) 1.87
Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival. Clin Cancer Res (2012) 1.84
The 5-year outcome of ABO-incompatible kidney transplantation with rituximab induction. Transplantation (2011) 1.82
Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg (2007) 1.82
FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma. Hepatology (2013) 1.81
Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. AJR Am J Roentgenol (2010) 1.79
Endoscopic management of biliary complications after adult living donor liver transplantation. Am J Gastroenterol (2006) 1.78
Report of the 15th follow-up survey of primary liver cancer. Hepatol Res (2004) 1.78
Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan. World J Gastroenterol (2006) 1.72
Experience with laparoscopic management of solitary symptomatic splenic cysts. Surg Laparosc Endosc Percutan Tech (2002) 1.69
Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Am J Surg Pathol (2008) 1.68
Acute Appendicitis in an Incarcerated Femoral Hernia: A Case of De Garengeot Hernia. Case Rep Gastroenterol (2009) 1.67
Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery (2003) 1.67
One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg (2006) 1.64
Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol (2005) 1.61
Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis (2007) 1.60
Refinement of venous reconstruction using cryopreserved veins in right liver grafts. Liver Transpl (2004) 1.59
One orifice vein reconstruction in left liver plus caudate lobe grafts. Transplantation (2007) 1.57
Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer. J Surg Oncol (2009) 1.57
Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer. J Surg Oncol (2006) 1.56
Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB (Oxford) (2011) 1.56
Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg (2005) 1.56
Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int J Cancer (2003) 1.54
Renoprotective effect of erythropoietin against ischaemia-reperfusion injury in a non-human primate model. Nephrol Dial Transplant (2010) 1.52
The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod Pathol (2005) 1.52
Portal vein complications after adult-to-adult living donor liver transplantation. Transpl Int (2008) 1.51
Systematic grading of morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.51
Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol (2003) 1.50
Loss of E-cadherin mRNA and gain of osteopontin mRNA are useful markers for detecting early recurrence of HCV-related hepatocellular carcinoma. J Surg Oncol (2005) 1.50
Transfusion criteria for fresh frozen plasma in liver resection: a 3 + 3 cohort expansion study. Arch Surg (2011) 1.50
Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg (2002) 1.49
Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer (2013) 1.49
Successful outcome after resection of pancreatic cancer with a solitary hepatic metastasis. Hepatogastroenterology (2004) 1.48
Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma. J Gastroenterol (2004) 1.48
Effect of billroth II or Roux-en-Y reconstruction for the gastrojejunostomy on delayed gastric emptying after pancreaticoduodenectomy: a randomized controlled study. Ann Surg (2013) 1.48
Applicability of enhanced recovery program for advanced liver surgery. World J Surg (2014) 1.48
Is spleen-preserving distal pancreatectomy with excision of the splenic artery and vein feasible? Surgery (2011) 1.47
Combined functional genome survey of therapeutic targets for hepatocellular carcinoma. Clin Cancer Res (2010) 1.47
Ultrasonically assisted retrohepatic dissection for a liver hanging maneuver. Ann Surg (2005) 1.46
Prognosis of patients undergoing hepatectomy for solitary hepatocellular carcinoma originating in the caudate lobe. Surgery (2011) 1.44
Hepatic arterial anatomy for right liver procurement from living donors. Liver Transpl (2004) 1.44
Evaluation of hepatic venous congestion: proposed indication criteria for hepatic vein reconstruction. Ann Surg (2002) 1.43
Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer (2002) 1.43
Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur J Cancer (2005) 1.42
Two-stage pancreatojejunostomy in pancreaticoduodenectomy: a retrospective analysis of short-term results. Am J Surg (2008) 1.41
Chimeric acceleration by donor CD4+CD25+T-reg depleted fraction in splenocyte transplantation. J Surg Res (2012) 1.41
Bile duct preserving surgery for hepatocellular carcinoma with bile duct tumor thrombus. Ann Surg (2015) 1.41